BioCentury
ARTICLE | Clinical News

Cx611: Phase I data

March 23, 2015 7:00 AM UTC

The open-label, placebo-controlled, Dutch Phase I CELLULA trial in 32 healthy volunteers challenged with a bacterial endotoxin showed that single doses of 250,000, 1,000,000 and 4,000,000 cells/kg IV ...